Fasl and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Rethi, Bence ^a   Eidsmo, Liv ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cutaneous leishmaniasis; Fasl; Immunopathology; Keratinocytes; Macrophages; Neutrophils; Trail; Ulceration

Indexed keywords

EID: 84870193420     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00163     Document Type: Short Survey

References (73)

1. Abe, R., Shimizu, T., Shibaki, A., Nakamura, H., Watanabe, H., and Shimizu, H. (2003). Toxic epider- mal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.Am.J.Pathol.162,1515-1520
2. Afonso, L., Borges, V. M., Cruz, H., Ribeiro-Gomes, F. L., Dosreis, G.A., Dutra, A. N., Clarencio, J., De Oliveira, C. I., Barral, A., Barral- Netto, M., and Brodskyn, C. I. (2008). Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishma- nia amazonensis. J. Leukoc. Biol. 84, 389-396.
3. Aga, E., Katschinski, D. M., van Zandbergen, G., Laufs, H., Hansen, B., Muller, K., Solbach, W., and Laskay, T. (2002). Inhibi- tion of the spontaneous apop- tosis of neutrophil granulocytes by the intracellular parasite Leish- mania major. J. Immunol. 169, 898-905.
4. Akuffo, H., Schurr, E., Andersson, G., Yamaneberhan, T., and Brit- ton, S. (1987). Responsiveness in diffuse versus local cutaneous leish- maniasis is due to parasite dif- ferences. Scand. J. Immunol. 26, 717-721.
5. Carneiro, F. P., De Magalhaes, A. V., De Jesus Abreu Almeida Couto, M.,Bocca, A. L., Muniz-Junqueira, M. I., and Ribeiro Sampaio, R. N. (2009). Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis. Parasite Immunol. 31,646-651.
6. Carvalho, E. M., Barral, A., Costa, J. M., Bittencourt, A., and Marsden, P. (1994). Clinical and immunopatho- logical aspects of disseminated cuta- neous leishmaniasis. Acta Trop. 56, 315-325.
7. Conceicao-Silva, F., Hahne, M., Schroter, M., Louis, J., and Tschopp, J. (1998). The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28,237-245.
8. Connor, D., Chandler, F., Schwartz, D., Manz, H., and Lack, E. (1997). Pathology of Infectious Diseases. Stam- ford,CT: Appleton & Lange.
9. Costa, J. M., Marsden, P. D., Llanos- Cuentas,E.A.,Netto,E.M.,Carvalho, E.M.,Barral,A.,Rosa,A.C.,Cuba,C. C., Magalhaes, A. V., and Barreto, A. C. (1986). Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J. Trop. Med. Hyg. 89,319-323.
10. Croker, B. A., O'Donnell, J. A., Nowell, C. J.,Metcalf,D.,Dewson,G.,Camp- bell,K.J.,Rogers,K.L.,Hu,Y.,Smyth, G. K., Zhang, J. G., White, M., Lack- ovic,K.,Cengia,L. H.,O'Reilly,L. A., Bouillet, P., Cory, S., Strasser, A., and Roberts, A. W. (2011). Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2andMcl-1.Proc.Natl.Acad.Sci. U.S.A. 108,13135-13140.
11. Dalton, J. E., and Kaye, P. M. (2010). Immunomodulators: use in com- bined therapy against leishmania- sis. Expert Rev. Anti Infect. Ther 8, 739-742.
12. Dalton, J. E., Maroof, A., Owens, B. M., Narang, P., Johnson, K., Brown, N., Rosenquist, L., Beat- tie, L., Coles, M., and Kaye, P. M. (2010). Inhibition of receptor tyrosine kinases restores immuno- competence and improves immune- dependent chemotherapy against experimental leishmaniasis in mice. J. Clin. Invest. 120,1204-1216.
13. de Araujo, E., Dessirier, V., Lapree, G., Valeyrie-Allanore, L., Ortonne, N., Stathopoulos, E. N., Bagot, M., Bensussan, A., Mockenhaupt, M., Roujeau, J. C., and Tsapis, A. (2011). Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epider- mal necrolysis. Exp. Dermatol. 20, 107-112.
14. Doerr,W.,and Seifert,G. (1995). Tropi- cal Pathology. Berlin: Springer.
15. Eidsmo, L., Fluur, C., Rethi, B., Eriks- son Ygberg, S., Ruffin, N., De Milito, A.,Akuffo, H., and Chiodi, F. (2007). FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major. Am. J. Pathol. 170,227-239.
16. Eidsmo, L., Nylen, S., Khamesipour, A., Hedblad, M. A., Chiodi, F., and Akuffo, H. (2005). The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishma- niasis. Am. J. Pathol. 166, 1099-1108
17. Eidsmo, L., Wolday, D., Berhe, N., Sabri, F., Satti, I., El Hassan, A. M., Sundar, S., Chiodi, F., and Akuffo, H. (2002). Alteration of Fas and Fas ligand expression during human visceral leishmaniasis. Clin. Exp. Immunol. 130,307-313.
18. ElHassan,A. M.,Gaafar,A.,and Thean- der, T. G. (1995). Antigen-presenting cells in human cutaneous leishmani- asis due to Leishmania major. Clin. Exp. Immunol. 99,445-453.
19. Falschlehner,C.,Emmerich,C. H.,Ger- lach, B., and Walczak, H. (2007). TRAIL signalling: decisions between life and death. Int. J. Biochem. Cell Biol. 39,1462-1475.
20. Farley, S. M., Dotson, A. D., Purdy, D. E., Sundholm, A. J., Schnei- der, P., Magun, B. E., and Ior- danov, M. S. (2006). Fas ligand elicits a caspase-independent pro- inflammatory response in human keratinocytes: implications for der- matitis. J. Invest. Dermatol. 126, 2438-2451.
21. Furze, R. C., and Rankin, S. M. (2008). The role of the bone marrow in neu- trophil clearance under homeostatic conditions in the mouse. FASEBJ.22, 3111-3119.
22. Gaafar,A.,ElKadaro,A.Y.,Theander,T. G., Permin, H., Ismail, A., Kharazmi, A., and El Hassan, A. M. (1995). Thepathology of cutaneousleishma- niasis due to Leishmania major in Sudan. Am. J. Trop. Med. Hyg. 52, 438-442.
23. Gaafar, A., Veress, B., Permin, H., Kharazmi, A., Theander, T. G., and El Hassan, A. M. (1999). Charac- terization of the local and systemic immune responses in patients with cutaneous leishmanias is due to Leishmania major. Clin. Immunol. 91, 314-320.
24. Giroux,M.,andDenis,F. (2005).CD1dunrestricted human NKT cell srelease chemokines upon Fas engagement. Blood 105, 703-710.
25. Goto, H., and Lindoso, J. A. (2010). Current diagnosis and treatment of cutaneous and mucocutaneous leish- maniasis. Expert Rev. Anti Infect. Ther. 8,419-433.
26. Gougeon, M. L. (2003). Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3, 392-404.
27. Guimaraes-Costa, A. B., Nascimento, M. T., Froment, G. S., Soares, R. P., Morgado, F. N., Conceicao- Silva, F., and Saraiva, E. M. (2009). Leishmania amazonensis promastig- otes induce and are killed by neu- trophil extracellular traps. Proc. Natl. Acad. Sci. U.S.A. 106, 6748-6753.
28. Guo, Z., Zhang, M., Tang, H., and Cao,X. (2005).Fassignallinksinnate and adaptive immunity by promot- ing dendritic-cell secretion of CC and CXC chemokines. Blood 106, 2033-2041.
29. Hao, Z., Duncan, G. S., Seagal, J., Su, Y. W., Hong, C., Haight, J., Chen, N. J., Elia, A., Wakeham, A., Li, W. Y., Liepa, J., Wood, G. A., Casola, S., Rajewsky, K., and Mak, T. W. (2008). Fas receptor expression in germinal- center B cells is essential for T and B lymphocyte homeostasis. Immunity 29,615-627.
30. Huang, F. P., Xu, D., Esfandiari, E. O., Sands, W., Wei, X. Q., and Liew, F. Y. (1998). Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL- 12 synthesis, strong Th1 responses, and enhanced nitric oxide produc- tion. J. Immunol. 160, 4143-4147.
31. Hughes,P. D.,Belz,G. T.,Fortner,K.A., Budd,R.C.,Strasser,A.,andBouillet, P. (2008). Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and pre- vention of autoimmunity. Immunity 28,197-205.
32. Iordanov, M. S., Sundholm,A. J., Simp- son, E. L., Hanifin, J. M., Ryabin- ina, O. P., Choi, R. J., Korcheva, V. B., Schneider, P., and Magun, B. E. (2005). Cell death-induced acti- vation of epidermal growth factor receptor in keratinocytes: implica- tions for restricting epidermal dam- age in dermatitis. J. Invest. Dermatol. 125,134-142.
33. Jansen, B. J., Van Ruissen, F., Cerneus, S., Cloin, W., Bergers, M., Van Erp, P. E., and Schalkwijk, J. (2003). Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes. J. Invest. Dermatol. 121,1433-1439
34. Konur, A., Schulz, U., Eissner, G., Andreesen, R., and Holler, E. (2005). Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes toautocrine IFN-gamma and tumour necrosis factor-alpha production. Br. J. Dermatol. 152,1134-1142.
35. Laskay, T., van Zandbergen, G., and Solbach, W. (2008). Neu- trophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection- promoting factor. Immunobiology 213,183-191.
36. Lee,S. H.,Jang,J. J.,Lee, J.Y.,Kim,S.Y., Park, W. S., Shin, M. S., Dong, S. M., Na,E.Y.,Kim,K.M.,Kim,C.S.,Kim, S. H., and Yoo, N. J. (1998). Fas lig- and is expressed in normal skin and in some cutaneous malignancies. Br. J. Dermatol. 139,186-191.
37. Lemma, A., Foster, W. A., Gemetchu, T., Preston, P. M., Bryceson, A., and Minter, D. M. (1969). Stud- ies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishma- niasis in the highlands. Ann. Trop. Med. Parasitol. 63, 455-472.
38. Leopoldo, P. T., Machado, P. R., Almeida, R. P., Schriefer, A., Giu- dice, A., De Jesus, A. R., Ho, J. L., Guimaraes, L. H., Bacellar, O., and Carvalho, E. M. (2006). Differential effects of antigens from L. brazilien- sis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production. BMC Infect. Dis. 6, 75. doi: 10.1186/1471-2334- 6-75
39. Leverkus, M., Neumann, M., Mengling, T., Rauch, C. T., Brocker, E. B., Krammer, P. H., and Walczak, H. (2000). Regulation of tumor necrosis factor-relatedapoptosis-inducinglig- and sensitivity in primary and trans- formed human keratinocytes. Cancer Res. 60,553-559.
40. Mabrouk, I., Buart, S., Hasmim, M., Michiels, C., Connault, E., Opolon, P., Chiocchia, G., Levi-Strauss, M., Chouaib, S., and Karray, S. (2008). Prevention of autoimmunity and control of recall response to exoge- nous antigen by Fas death receptor ligand expression on T cells. Immu- nity 29,922-933.
41. Machado, P. R., Rosa, M. E., Costa, D., Mignac, M., Silva, J. S., Schriefer, A., Teixeira, M. M., Bacellar, O., and Carvalho, E. M. (2011). Reappraisal of the immunopathogenesis of dis- seminated leishmaniasis: in situ and systemic immune response. Trans. R. Soc. Trop. Med. Hyg. 105,438-444.
42. Majai, G., Gogolak, P., Ambrus, C., Vereb, G., Hodrea, J., Fesus, L., and Rajnavolgyi, E. (2010). PPARgamma modulated inflammatory response of human dendritic cell subsets to engulfed apoptotic neutrophils. J. Leukoc. Biol. 88, 981-991.
43. Maksimow, M., Santanen, M., Jalka- nen, S., and Hanninen, A. (2003). Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cell is scompensated by costimulation of surviving T cells. Blood 101,4022-4028.
44. Mishra, J., Saxena, A., and Singh, S. (2007). Chemotherapy of leishmani- asis: past, present and future. Curr. Med. Chem. 14, 1153-1169.
45. Moir, S., and Fauci, A. S. (2009). B cells in HIV infection and disease. Nat. Rev. Immunol. 9, 235-245.
46. Mustafa, T., Bjune, T. G., Jonsson, R., Pando, R. H., and Nilsen, R. (2001). Increased expression of fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacte- rial infection. Scand. J. Immunol. 54, 630-639.
47. Ng, L. G., Hsu, A., Mandell, M. A., Roediger, B., Hoeller, C., Mrass, P., Iparraguirre, A., Cavanagh, L. L., Triccas, J. A., Beverley, S. M., Scott, P., and Weninger, W. (2008). Migratory dermal dendritic cells act as rapid sensors of protozoan para- sites. PLoS Pathog. 4, e1000222. doi: 10.1371/journal.ppat.1000222
48. Nguyen, X. H., Lang, P. A., Lang, K. S., Adam, D., Fattakhova, G., Foger, N., Kamal, M. A., Prilla, P., Mathieu, S., Wagner,C.,Mak,T.,Chan,A. C.,and Lee, K. H. (2011). Toso regulates the balance between apoptotic and non- apoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood 118, 598-608.
49. Nilsen, R., and Mshana, R. N. (1987). In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis. Scand. J. Immunol. 26,503-512.
50. Oliveira, F., Bafica, A., Rosato, A. B., Favali, C. B., Costa, J. M., Cafe, V., Barral-Netto, M., and Barral, A. (2011). Lesion size correlates with Leishmania antigen-stimulated TNF- levels in human cutaneous leishma- niasis. Am. J. Trop. Med. Hyg. 85, 70-73.
51. Palmeiro,M. R.,Morgado,F. N.,Valete- Rosalino,C. M.,Martins,A. C.,Mor- eira, J., Quintella, L. P., De Oliveira Schubach, A., and Conceicao-Silva, F. (2012). Comparative study of the in situ immune response in oral and nasal mucosal leishmaniasis. Parasite Immunol. 34,23-31.
52. Peter, M. E., Budd, R. C., Desbarats, J., Hedrick, S. M., Hueber, A. O., Newell, M. K., Owen, L. B., Pope, R. M., Tschopp, J., Wajant, H., Wal- lach, D., Wiltrout, R. H., Zornig, M., and Lynch, D. H. (2007). The CD95 receptor: apoptosis revisited. Cell 129,447-450.
53. Peters, N. C., Egen, J. G., Secundino, N., Debrabant, A., Kimblin, N., Kamhawi, S., Lawyer, P., Fay, M. P., Germain,R.N.,andSacks,D. (2008). In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sandflies. Science 321, 970-974.
54. Prasad, N. K., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., and Kaveri, S. V. (1998). Therapeutic preparations of normal polyspecific IgG (IVIg) induce apop- tosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.J.Immunol.161,3781- 3790.
55. Rethi, B., Vivar, N., Sammicheli, S., Fluur, C., Ruffin, N., Atlas, A., Raj- navolgyi, E., and Chiodi, F. (2008). Priming of T cells to Fas-mediated proliferative signals by interleukin-7. Blood 112, 1195-1204.
56. Ribeiro-Gomes,F. L.,Moniz-De-Souza, M. C., Borges, V. M., Nunes, M. P., Mantuano-Barradas, M., D'Avila, H., Bozza,P.T.,Calich,V.L.,andDosreis, G.A. (2005).Turnoverof neutrophils mediated by Fas ligand drives Leish- mania major infection. J. Infect. Dis. 192,1127-1134.
57. Ribeiro-Gomes, F. L., Otero, A. C., Gomes, N. A., Moniz-De-Souza, M. C., Cysne-Finkelstein, L., Arnholdt, A. C., Calich, V. L., Coutinho, S. G., Lopes, M. F., and Dosreis, G. A. (2004). Macrophage interactions with neutrophils regulate Leishma- nia major infection. J. Immunol. 172, 4454-4462.
58. Ritter, U., Mattner, J., Rocha, J. S., Bog- dan, C., and Korner, H. (2004). The control of Leishmania (Leishmania) major by TNF invivo is dependent on the parasite strain. Microbes Infect. 6, 559-565.
59. Schmidt, M., Hupe, M., Endres, N., Raghavan, B., Kavuri, S., Geserick, P., Goebeler, M., and Leverkus, M. (2010). The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAILmediated apoptosis.J.Cell.Mol.Med. 14,1760-1776.
60. Stander, S., and Schwarz, T. (2005). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed in normal skin and cutaneous inflammatory diseases, but not in chronically UV-exposed skin and non-melanoma skin cancer. Am. J. Dermatopathol 27,116-121.
61. Stranges, P. B., Watson, J., Cooper, C. J., Choisy-Rossi, C. M., Stonebraker, A. C., Beighton, R. A., Hartig, H., Sundberg, J. P., Servick, S., Kauf- mann,G.,Fink,P.J.,andChervonsky, A. V. (2007). Elimination of antigen- presenting cells and autoreactive T cells by Fas contributes to preven- tion of autoimmunity. Immunity 26, 629-641.
62. Tasew, G., Nylen, S., Lieke, T., Lemu, B., Meless, H., Ruffin, N., Wolday, D., Asseffa, A., Yagita, H., Britton, S., Akuffo, H., Chiodi, F., and Eidsmo, L. (2010). Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration. PLoS Negl. Trop. Dis. 4, e844. doi: 10.1371/ journal.pntd.0000844
63. Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H. U., Graeve, T., Noll, M., Brocker, E. B., Blaser, K., and Akdis, C. A. (2000). T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous der- matitis. J. Clin. Invest. 106, 25-35.
64. Turbyville, J. C., and Rao, V. K. (2010). The autoimmune lympho- proliferative syndrome: a rare dis- order providing clues about nor- mal tolerance. Autoimmun. Rev. 9, 488-493.
65. Turetz, M. L., Machado, P. R., Ko, A. I., Alves, F., Bittencourt, A., Almeida, R. P., Mobashery, N., Johnson, W. D. Jr., and Carvalho, E. M. (2002). Disseminated leishmaniasis: a new and emerging form of leishmania- sis observed in northeastern Brazil. J. Infect. Dis. 186,1829-1834.
66. vanGrevenynghe,J.,Cubas,R.A.,Noto, A., Dafonseca, S., He, Z., Peretz, Y., Filali-Mouhim, A., Dupuy, F. P., Pro- copio, F. A., Chomont, N., Balderas, R. S., Said, E. A., Boulassel, M. R., Tremblay,C. L.,Routy,J. P.,Sekaly,R. P., and Haddad, E. K. (2011). Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. J. Clin. Invest. 121,3877-3888.
67. van Zandbergen, G., Klinger, M., Mueller, A., Dannenberg, S., Gebert, A.,Solbach,W.,andLaskay,T. (2004). Cutting edge: neutrophil granulocyte serves as a vector for Leishmaniaentry into macrophages. J. Immunol. 173, 6521-6525.
68. Vassina, E., Leverkus, M., Yousefi, S., Braathen, L. R., Simon, H. U., and Simon, D. (2005). Increased expression and a potential antiinflammatory role of TRAIL in atopic dermatitis. J. Invest. Dermatol. 125, 746-752.
69. Viard, I., Wehrli, P., Bullani, R., Schnei- der, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J. H., Tschopp, J., and French, L. E. (1998). Inhi- bition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Sci- ence 282,490-493.
70. Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Rollinghoff, M., Bog- dan, C., and Korner, H. (2001). Rapidly fatal leishmaniasis in resis- tant C57BL/6 mice lacking TNF. J. Immunol. 166,4012-4019.
71. Wilhelm, P., Wiede, F., Meissner, A., Donhauser, N., Bogdan, C., and Korner, H. (2005). TNF but not Fas ligand provides protective anti- L. major immunity in C57BL/6 mice. Microbes Infect. 7, 1461-1468.
72. Wu,N. L.,Lee,T.A.,Tsai,T. L.,and Lin, W. W. (2011). TRAIL-induced keratinocyte differentiation requires caspase activation and p63 expression. J. Invest. Dermatol. 131,874-883.
73. Zaba, L. C., Fuentes-Duculan, J., Eung- damrong, N. J., Johnson-Huang, L. M.,Nograles,K.E.,White,T.R.,Pier- son,K.C.,Lentini,T.,Suarez-Farinas, M., Lowes, M. A., and Krueger, J. G. (2010). Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.J.AllergyClin. Immunol. 125,1261-1268 e1269.